Alkem Laboratories Ltd.NSE: ALKEM

Press Release Aug 04 2021

· Issued by Alkem Laboratories Ltd.

Filed with NSE ·

Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2021, titled "ALKEM launches Ibuprofen and Famotidine Tablets in the United States.".

View Attachment

6ix hasn’t read this filing yet.

Alkem Laboratories Ltd. on 6ix

In the deck

Earlier from Alkem Laboratories

Later from Alkem Laboratories

All Alkem Laboratories news releases